To study the relationship between the hypoxia-inducible factor-1 (HIF-1) activity level after bevacizumab treatment and the antitumor effects of radiation to determine the optimal combination schedule of bevacizumab with radiotherapy.
Department of Radiation Oncology, Cancer Hospital Institute, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
